Donna Harrington
Neurology · Tupelo, MSNPI 1093708232
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.1% of the total across 379 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 22.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,928 and has fallen 94.8% since, to $100 in 2025.
Across 379 payments — averaging $14.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Teva Pharmaceuticals USA, Inc.$594
- Sanofi$415
- Acorda Therapeutics, Inc$328
- Avanir Pharmaceuticals, Inc.$284
- Biohaven Pharmaceuticals, Inc.$242
- plus $2K from 26 others
What the payments were for
- Speaking & faculty fees$2885%
- Food & beverage$5,20593%
- Education$1002%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 94 | $1,258 |
| Teva Pharmaceuticals USA, Inc. | 41 | $594 |
| Sanofi | 24 | $415 |
| Acorda Therapeutics, Inc | 17 | $328 |
| Avanir Pharmaceuticals, Inc. | 21 | $284 |
| Biohaven Pharmaceuticals, Inc. | 18 | $242 |
| Supernus Pharmaceuticals, Inc. | 22 | $237 |
| Genentech USA, Inc. | 14 | $213 |
| Medtronic(2 entities) | 15 | $209 |
| Lilly USA, LLC | 13 | $177 |
| Piramal Critical Care | 12 | $176 |
| Amgen | 11 | $175 |
| AstraZeneca(2 entities) | 8 | $108 |
| UCB, Inc. | 8 | $105 |
| Johnson & Johnson | 1 | $100 |
| Acadia Pharmaceuticals Inc | 7 | $97 |
| Novartis | 5 | $91 |
| Lundbeck LLC | 5 | $84 |
| SK Life Science, Inc. | 5 | $83 |
| Neurocrine Biosciences, Inc. | 6 | $81 |
| Amneal Pharmaceuticals LLC | 5 | $71 |
| Biogen | 4 | $71 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $69 |
| Tanabe Pharma America, Inc. | 4 | $68 |
| Jazz Pharmaceuticals Inc. | 3 | $62 |
| Sunovion Pharmaceuticals Inc. | 4 | $59 |
| Boston Scientific | 2 | $34 |
| Catalyst Pharmaceuticals, Inc. | 2 | $29 |
| CSL Behring | 1 | $28 |
| Harmony Biosciences LLC | 1 | $19 |
| EMD Serono, Inc. | 1 | $16 |
| Assertio Therapeutics, Inc. | 1 | $12 |
How this compares
$5,593 in reported general payments places this provider in the 60th percentile of 111 neurology providers in Mississippi.
Other neurology in Tupelo
- Stephen LandyTupelo$1.9M
- Justin GraffTupelo$85K
- Mark FletcherTupelo$41K
- Samuel NewellTupelo$10K
- William OakesTupelo$3K
- Ali AhmadTupelo$2K
- Esther FischerTupelo$2K
- Ruth FredericksJackson$943K
- Wendell HelvestonJackson$883K
- Ronald SchwartzHattiesburg$352K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.